A Note on the Minimax Solution for the Two-Stage Group Testing Problem

被引:6
|
作者
Malinovsky, Yaakov [1 ]
Albert, Paul S. [2 ]
机构
[1] Univ Maryland, Dept Math & Stat, Baltimore, MD 21250 USA
[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Biostat & Bioinformat Branch, Div Intramural Populat Hlth Res, Bethesda, MD 20892 USA
关键词
Loss function; Optimal design; Optimization problem; COST; PRIORS; HIV; DISTRIBUTIONS; INFECTIONS; DEFECTIVES;
D O I
10.1080/00031305.2014.983545
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
Group testing is an active area of current research and has important applications in medicine, biotechnology, genetics, and product testing. There have been recent advances in design and estimation, but the simple Dorfman procedure introduced by R. Dorfman in 1943 is widely used in practice. In many practical situations, the exact value of the probability p of being affected is unknown. We present both minimax and Bayesian solutions for the group size problem when p is unknown. For unbounded p, we show that the minimax solution for group size is 8, while using a Bayesian strategy with Jeffreys' prior results in a group size of 13. We also present solutions when p is bounded from above. For the practitioner, we propose strong justification for using a group size of between 8 and 13 when a constraint on p is not incorporated and provide useable code for computing the minimax group size under a constrained p.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [1] A Two-Stage Group Testing Model for Infections with Window Periods
    Bar-Lev, Shaul K.
    Boxma, Onno
    Stadje, Wolfgang
    Schouten, Frank A. Van der Duyn
    METHODOLOGY AND COMPUTING IN APPLIED PROBABILITY, 2010, 12 (03) : 309 - 322
  • [2] Two-Stage Hierarchical Group Testing for Multiple Infections with Application to the Infertility Prevention Project
    Tebbs, Joshua M.
    McMahan, Christopher S.
    Bilder, Christopher R.
    BIOMETRICS, 2013, 69 (04) : 1064 - 1073
  • [3] Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
    Fei Qin
    Jingwei Wu
    Feng Chen
    Yongyue Wei
    Yang Zhao
    Zhiwei Jiang
    Jianling Bai
    Hao Yu
    BMC Medical Research Methodology, 20
  • [4] Optimal two-stage group-sequential designs
    Lokhnygina, Yuliya
    Tsiatis, Anastasios A.
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2008, 138 (02) : 489 - 499
  • [5] Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
    Qin, Fei
    Wu, Jingwei
    Chen, Feng
    Wei, Yongyue
    Zhao, Yang
    Jiang, Zhiwei
    Bai, Jianling
    Yu, Hao
    BMC MEDICAL RESEARCH METHODOLOGY, 2020, 20 (01)
  • [6] A note on the shape of sample size functions of optimal adaptive two-stage designs
    Pilz, Maximilian
    Kilian, Samuel
    Kieser, Meinhard
    COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 2022, 51 (06) : 1911 - 1918
  • [7] Boundary problem in Simon's two-stage clinical trial designs
    Shan, Guogen
    Chen, John J.
    Ma, Changxing
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2017, 27 (01) : 25 - 33
  • [8] Bayesian testing for independence of two categorical variables under two-stage cluster sampling with covariates
    Bhatta, Dilli
    Nandram, Balgobin
    Sedransk, Joseph
    JOURNAL OF APPLIED STATISTICS, 2018, 45 (13) : 2365 - 2393
  • [9] TWO-STAGE PRIORITIZATION PROCEDURE FOR MULTIPLICATIVE AHP-GROUP DECISION MAKING
    Lin, Changsheng
    Kou, Gang
    Peng, Yi
    Alsaadi, Fawaz E.
    TECHNOLOGICAL AND ECONOMIC DEVELOPMENT OF ECONOMY, 2020, 26 (02) : 525 - 545
  • [10] Two-Stage Robust Unit Commitment Problem With Complex Temperature and Demand Uncertainties
    Wang, Wei
    Danandeh, Anna
    Buckley, Brian
    Zeng, Bo
    IEEE TRANSACTIONS ON POWER SYSTEMS, 2024, 39 (01) : 909 - 920